The Effects of Pre-Existing Antibodies on Live-Attenuated Viral Vaccines

The Effects of Pre-Existing Antibodies on Live-Attenuated Viral Vaccines

Live-attenuated vaccines (LAVs) have achieved remarkable successes in controlling virus spread, as well as for other applications such as cancer immunotherapy. However, with rapid increases in international travel, globalization, geographic spread of viral vectors, and widespread use of vaccines, th...

Full description

Bibliographic Details
Main Authors:	Darren Z. L. Mok, Kuan Rong Chan
Format:	Article
Language:	English
Published:	MDPI AG 2020-05-01
Series:	Viruses
Subjects:	live-attenuated vaccine vaccine immunogenicity antibody-dependent enhancement vaccine immune interference pre-existing antibodies
Online Access:	https://www.mdpi.com/1999-4915/12/5/520

Similar Items

Impact of Pre-Existing Immunity to Influenza on Live-Attenuated Influenza Vaccine (LAIV) Immunogenicity
by: Sreeja Roy, et al.
Published: (2020-11-01)

Influenza Vaccination Strategies: Comparing Inactivated and Live Attenuated Influenza Vaccines
by: Saranya Sridhar, et al.
Published: (2015-04-01)

Study of Neuraminidase-Inhibiting Antibodies in Clinical Trials of Live Influenza Vaccines
by: Yulia Desheva, et al.
Published: (2020-05-01)

Opposing Effects of Prior Infection versus Prior Vaccination on Vaccine Immunogenicity against Influenza A(H3N2) Viruses
by: Annette Fox, et al.
Published: (2022-02-01)

Immune Responses Elicited by Live Attenuated Influenza Vaccines as Correlates of Universal Protection against Influenza Viruses
by: Yo Han Jang, et al.
Published: (2021-04-01)

Viral interference and the live-attenuated intranasal influenza vaccine: Results from a pediatric cohort with cystic fibrosis
by: Constantina Boikos, et al.
Published: (2017-06-01)

Immune responses after live attenuated influenza vaccination
by: Kristin G.-I. Mohn, et al.
Published: (2018-03-01)

Humanized Mice for Live-Attenuated Vaccine Research: From Unmet Potential to New Promises
by: Aoife K. O’Connell, et al.
Published: (2020-01-01)

A New Master Donor Virus for the Development of Live-Attenuated Influenza B Virus Vaccines
by: Chantelle L. White, et al.
Published: (2021-06-01)

Modeling the long-term persistence of neutralizing antibody in children and toddlers after vaccination with live attenuated Japanese encephalitis chimeric virus vaccine
by: Alain Bouckenooghe, et al.
Published: (2019-01-01)

Mutating chikungunya virus non‐structural protein produces potent live‐attenuated vaccine candidate
by: Yi‐Hao Chan, et al.
Published: (2019-06-01)

Addition of Partial Envelope Domain II into Envelope Domain III of Dengue Virus Antigen Potentiates the Induction of Virus-Neutralizing Antibodies and Induces Protective Immunity
by: Jisang Park, et al.
Published: (2020-02-01)

Rational Development of Live-Attenuated Zika Virus Vaccines
by: Awadalkareem Adam, et al.
Published: (2023-01-01)

Review of long term immunogenicity and tolerability of live hepatitis A vaccine
by: Nitin Shah, et al.
Published: (2020-11-01)

Longitudinal study of antibody response following SARS-CoV-2 vaccination with Pfizer-BioNTech BNT162b2
by: Robles Navas Leandra J., et al.
Published: (2023-08-01)

Safety and Efficacy of Spray Intranasal Live Attenuated Influenza Vaccine: Systematic Review and Meta-Analysis
by: Giulia Perego, et al.
Published: (2021-09-01)

A novel live attenuated duck Tembusu virus vaccine targeting N7 methyltransferase protects ducklings against pathogenic strains
by: Xuedong Wu, et al.
Published: (2023-06-01)

Immunogenicity and Safety of a Booster Dose of Live Attenuated Varicella Vaccine, and Immune Persistence of a Primary Dose for Children Aged 2 to 6 Years
by: Yukai Zhang, et al.
Published: (2022-04-01)

Manufacture of a Stable Lyophilized Formulation of the Live Attenuated Pertussis Vaccine BPZE1
by: Marcel Thalen, et al.
Published: (2020-09-01)

Role of pre-existing immunity in driving the dengue virus serotype 2 genotype shift in the Philippines: A retrospective analysis of serological data
by: Jean Claude Balingit, et al.
Published: (2024-02-01)

Live Viral Vaccine Neurovirulence Screening: Current and Future Models
by: Corey May Fulton, et al.
Published: (2021-06-01)

Safety and immunogenicity of a single dose, live-attenuated ‘tetravalent dengue vaccine’ in healthy Indian adults; a randomized, double-blind, placebo controlled phase I/II trial
by: Lalitendu Mohanty, et al.
Published: (2022-04-01)

Live viral vaccines in transplanted patients
by: Arnaud G. L’Huillier, et al.
Published: (2014-09-01)

Comparative Analysis of Swine Antibody Responses following Vaccination with Live-Attenuated and Killed African Swine Fever Virus Vaccines
by: Hung Q. Luong, et al.
Published: (2023-11-01)

Rational Design of Live-Attenuated Vaccines against Herpes Simplex Viruses
by: Brent A. Stanfield, et al.
Published: (2021-08-01)

Investigation of Potency and Safety of Live-Attenuated Peste des Petits Ruminant Virus Vaccine in Goats by Detection of Cellular and Humoral Immune Response
by: Milovan Milovanović, et al.
Published: (2023-06-01)

Interseason waning of vaccine-induced hemagglutination inhibition antibody titers and contributing factors to pre-existing humoral immunity against influenza in community-dwelling older adults 75 years and older
by: Bettina Wunderlich, et al.
Published: (2023-07-01)

Effectiveness of Live-Attenuated Genotype III Japanese Encephalitis Viral Vaccine against Circulating Genotype I Viruses in Swine
by: Yi-Chin Fan, et al.
Published: (2022-01-01)

LIVING MICROORGANISM’S STABILYZATION IN BIOMASS BIOTECHNOLOGY AND PLAGUE VACCINE PREPARATION
by: D. A. Budika, et al.
Published: (2016-06-01)

Evaluation of the Delivery of a Live Attenuated Porcine Reproductive and Respiratory Syndrome Virus as a Unit Solid Dose Injectable Vaccine
by: Ellie Hayhurst, et al.
Published: (2022-10-01)

Dengue virus neutralizing antibody: a review of targets, cross-reactivity, and antibody-dependent enhancement
by: Animesh Sarker, et al.
Published: (2023-06-01)

Rapidly Declining SARS-CoV-2 Antibody Titers within 4 Months after BNT162b2 Vaccination
by: Dong-Ho Jo, et al.
Published: (2021-10-01)

Evaluation of a Combined Live Attenuated Vaccine against Lumpy Skin Disease, Contagious Bovine Pleuropneumonia and Rift Valley Fever
by: Zohra Bamouh, et al.
Published: (2024-03-01)

Increasing the Safety Profile of the Master Donor Live Attenuated Influenza Vaccine
by: Thomas A. Hilimire, et al.
Published: (2020-01-01)

Immunogenicity and safety of an inactivated enterovirus 71 vaccine co-administered with measles-mumps-rubella vaccine and live-attenuated Japanese encephalitis vaccine: a phase 4, single-center, randomized controlled trial
by: Xiaoyu Liu, et al.
Published: (2021-12-01)

An overview of VaxchoraTM, a live attenuated oral cholera vaccine
by: Tarun Saluja, et al.
Published: (2020-01-01)

Cost-Effectiveness of Intranasal Live-Attenuated Influenza Vaccine for Children: A Systematic Review
by: Kenneth Sik-Kwan Chan, et al.
Published: (2022-09-01)

Immunogenicity and efficacy of an oral live-attenuated vaccine for bovine Johne’s disease
by: Razieh Eshraghisamani, et al.
Published: (2024-01-01)

Effects of maternal antibodies in infants on the immunogenicity and safety of inactivated polio vaccine in infants
by: Shuyu Gao, et al.
Published: (2022-11-01)

Five-year antibody persistence in children after one dose of inactivated or live attenuated hepatitis A vaccine
by: Zhilun Zhang, et al.
Published: (2017-06-01)